-
NEWS RELEASE
Cholangiocarcinoma and Primary sclerosing cholangitis
2024.02.15
On February 15, World Cholangiocarcinoma Day!
-
NEWS RELEASE
Press Release Regarding STAM-HCC/IO+ Mice has been distributed.
2024.02.07
We are pleased to announce that our STAM(TM)-HCC/IO+ mouse was introduced in PR Newswire (Kyodo News JBN).
-
PUBLICATION
2024.02.01
We introduce a case study of drug efficacy evaluation of anti-claudin-1 antibody using our chronic kidney disease model, UUO model.
-
NEWS RELEASE
2024.01.23
Today, we are excited to invite you to join our Webinar that will be taking place on January 25th from 9:30 AM (JST).
-
PRODUCTS AND SERVICES
2024.01.16
Today, we would like to introduce a demonstration example of a drug efficacy evaluation test of a bacterial consortium consisting of nine types of intestinal resident bacteria using STAMTM mouse (hereinafter "STAM mouse"), which was published in May 2022 in the journal Biomedicines by a research team from Belgium's MRM Health. I would like to introduce you.
-
NEWS RELEASE
Fibrosis is involved in many diseases and disease-related deaths
2023.12.20
Today's topic is Fibrosis.
-
PRODUCTS AND SERVICES
Introduction of bleomycin-induced SSc-ILD model
2023.12.13
Today, we would like to introduce a more clinically correlative model in which skin and lung fibrosis develop simultaneously.
-
PRODUCTS AND SERVICES
STAM™ mice study: demonstration of MSCs-based cell therapy study for the NASH treatment
2023.12.08
We introduce an example of a drug evaluation study on the efficacy of cell therapy in the treatment of NASH using our STAM™ mice, model of non-alcoholic steatohepatitis (NASH).
-
PUBLICATION
2023.11.30
SMC is proud to announce that Marshall University (WV) has published the results of their study using our pre-clinical services with the STAM™ mice in Cells.
-
NEWS RELEASE
World COPD Day 2023 | “Breathing is Life - Act Earlier”
2023.11.15
November 15th is World COPD Day, so why not learn more about COPD?
-
PUBLICATION
2023.11.09
We are pleased to announce that our client AprilBio Co., Ltd. (KOR) published the results of preclinical studies of IL-18 inhibitor using our DDC-induced primary sclerosing cholangitis (PSC) mouse model in the journal Biomed Pharmacother.
-
PUBLICATION
2023.11.02
We will be presenting our study on STAM™ mice at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting to be held in Boston, MA on November 10-14, 2023.